Luca Visani

1.1k total citations
40 papers, 339 citations indexed

About

Luca Visani is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Luca Visani has authored 40 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 13 papers in Oncology and 12 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Luca Visani's work include Breast Cancer Treatment Studies (8 papers), Radiopharmaceutical Chemistry and Applications (7 papers) and Brain Metastases and Treatment (7 papers). Luca Visani is often cited by papers focused on Breast Cancer Treatment Studies (8 papers), Radiopharmaceutical Chemistry and Applications (7 papers) and Brain Metastases and Treatment (7 papers). Luca Visani collaborates with scholars based in Italy, France and Netherlands. Luca Visani's co-authors include Isacco Desideri, Lorenzo Livi, Daniela Greto, Giulio Francolini, Mauro Loi, Icro Meattini, Pierluigi Bonomo, Carlotta Becherini, Beatrice Detti and Viola Salvestrini and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and European Heart Journal.

In The Last Decade

Luca Visani

36 papers receiving 334 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Luca Visani Italy	11	177	151	78	74	68	40	339
Maria Ausilia Teriaca Italy	10	135 0.8×	101 0.7×	41 0.5×	63 0.9×	48 0.7×	30	267
Simona Borghesi Italy	13	194 1.1×	129 0.9×	160 2.1×	73 1.0×	58 0.9×	38	423
Roman O. Kowalchuk United States	11	144 0.8×	84 0.6×	37 0.5×	98 1.3×	61 0.9×	50	367
Salvatore Cozzi Italy	14	216 1.2×	112 0.7×	65 0.8×	68 0.9×	67 1.0×	46	422
Chan Woo Wee South Korea	13	152 0.9×	89 0.6×	42 0.5×	80 1.1×	170 2.5×	55	398
Rajayogesh Davuluri United States	6	155 0.9×	222 1.5×	28 0.4×	127 1.7×	26 0.4×	10	388
Emily S. Lebow United States	12	380 2.1×	378 2.5×	51 0.7×	92 1.2×	107 1.6×	33	586
F. Meacci Italy	7	145 0.8×	93 0.6×	109 1.4×	47 0.6×	86 1.3×	19	354
Alexandra Jensen Germany	9	136 0.8×	129 0.9×	37 0.5×	133 1.8×	26 0.4×	12	428
Martin Doležel Czechia	12	198 1.1×	92 0.6×	53 0.7×	109 1.5×	22 0.3×	55	423

Countries citing papers authored by Luca Visani

Since Specialization

Citations

This map shows the geographic impact of Luca Visani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luca Visani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luca Visani more than expected).

Fields of papers citing papers by Luca Visani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luca Visani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luca Visani. The network helps show where Luca Visani may publish in the future.

Co-authorship network of co-authors of Luca Visani

This figure shows the co-authorship network connecting the top 25 collaborators of Luca Visani. A scholar is included among the top collaborators of Luca Visani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luca Visani. Luca Visani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Banini, Marco, Daniela Greto, Luca Visani, et al.. (2025). Integrating Radiomics and Artificial Intelligence (AI) in Stereotactic Body Radiotherapy (SBRT)/Stereotactic Radiosurgery (SRS): Predictive Tools for Tailored Cancer Care. Cancers. 17(17). 2906–2906. 1 indexed citations

Mattioli, Camilla Ciolli, Luca Visani, Isacco Desideri, et al.. (2024). Single center analysis of safety profile and survival outcomes of intracranial radiation therapy in combination with trastuzumab-emtansine (T-DM1). European Journal of Cancer. 200. 113706–113706.

Becherini, Carlotta, Viola Salvestrini, Isacco Desideri, et al.. (2024). Impact of fosaprepitant in the prevention of nausea and emesis in head and neck cancer patients undergoing cisplatin-based chemoradiation: a pilot prospective study and a review of literature. La radiologia medica. 129(3). 457–466. 1 indexed citations

Zampieri, Mattia, Icro Meattini, Luca Visani, et al.. (2024). Cancer Treatment–Related Complications in Patients With Hypertrophic Cardiomyopathy. Mayo Clinic Proceedings. 99(2). 218–228. 1 indexed citations

Visani, Luca, Ivica Ratoša, Domen Ribnikar, et al.. (2024). Safety of trastuzumab deruxtecan and radiation therapy combination in HER2-positive metastatic breast cancer patients. European Journal of Cancer. 200. 113730–113730.

Bernini, Marco, Carlotta Becherini, Viola Salvestrini, et al.. (2024). Pre-pectoral breast reconstruction with tissue expander entirely covered by acellular dermal matrix: feasibility, safety and histological features resulting from the first 64 procedures. Gland Surgery. 13(3). 297–306. 2 indexed citations

Meattini, Icro, Carlotta Becherini, Luca Visani, et al.. (2023). Abstract PD8-03: Beta blockers and/or ACE inhibitors as cardioprotective strategy for patients affected by nonmetastatic breast cancer who are receiving an anthracycline-based chemotherapy (SAFE - NCT02236806): final results of a randomized trial. Cancer Research. 83(5_Supplement). PD8–3.

Francolini, Giulio, Arunangshu Ghoshal, Saverio Caini, et al.. (2023). Quality of life after definitive treatment for bladder cancer: A systematic review and meta-analysis. Radiotherapy and Oncology. 190. 110038–110038. 7 indexed citations

Francolini, Giulio, Vanessa Di Cataldo, Saverio Caini, et al.. (2022). 1369P Biochemical outcomes from ARTO trial (NCT03449719) a phase II randomized trial testing association between abiraterone acetate and stereotactic body radiation therapy in castrate-resistant prostate cancer patients. Annals of Oncology. 33. S1167–S1168. 1 indexed citations

10.

Desideri, Isacco, Sara Lucidi, Giulio Francolini, et al.. (2022). Use of an alfa-lipoic, Methylsulfonylmethane, Boswellia serrata and Bromelain dietary supplement (OPERA®) for aromatase inhibitors-related arthralgia management (AIA): a prospective phase II trial (NCT04161833). Medical Oncology. 39(8). 113–113. 3 indexed citations

11.

Francolini, Giulio, Beatrice Detti, Vanessa Di Cataldo, et al.. (2022). Study protocol and preliminary results from a mono-centric cohort within a trial testing stereotactic body radiotherapy and abiraterone (ARTO-NCT03449719). La radiologia medica. 127(8). 912–918. 5 indexed citations

12.

Visani, Luca, Lorenzo Livi, Ivica Ratoša, et al.. (2022). Safety of CDK4/6 inhibitors and concomitant radiation therapy in patients affected by metastatic breast cancer. Radiotherapy and Oncology. 177. 40–45. 3 indexed citations

13.

Miglietta, Federica, Luca Visani, Gaia Griguolo, et al.. (2022). Oligometastatic breast cancer: Dissecting the clinical and biological uniqueness of this emerging entity. Can we pursue curability?. Cancer Treatment Reviews. 110. 102462–102462. 11 indexed citations

14.

Meattini, Icro, Philip Poortmans, L. Marrazzo, et al.. (2020). Exclusive endocrine therapy or partial breast irradiation for women aged ≥70  years with luminal A-like early stage breast cancer (NCT04134598 – EUROPA): Proof of concept of a randomized controlled trial comparing health related quality of life by patient reported outcome measures. Journal of Geriatric Oncology. 12(2). 182–189. 33 indexed citations

15.

Desideri, Isacco, Giulio Francolini, Giulio Alberto Carta, et al.. (2019). Efficacy and Tolerability of CyberKnife Stereotactic Robotic Radiotherapy for Primary or Secondary Orbital Lesions: A Single-Center Retrospective Experience. Technology in Cancer Research & Treatment. 18. 1077086209–1077086209. 1 indexed citations

16.

Livi, Lorenzo, Vieri Scotti, Isacco Desideri, et al.. (2019). Phase 2 placebo-controlled, single-blind trial to evaluate the impact of oral ibandronate on bone mineral density in osteopenic breast cancer patients receiving adjuvant aromatase inhibitors: 5-year results of the single-centre BONADIUV trial. European Journal of Cancer. 108. 100–110. 13 indexed citations

17.

Francolini, Giulio, Isacco Desideri, Beatrice Detti, et al.. (2019). Stereotactic radiotherapy in oligoprogressive and oligorecurrent urothelial cancer patients: A retrospective experience.. Cancer Treatment and Research Communications. 19. 100124–100124. 13 indexed citations

18.

Borghetti, Paolo, Marco Lorenzo Bonù, Niccolò Giaj‐Levra, et al.. (2019). Concomitant radiotherapy and TKI in metastatic EGFR- or ALK-mutated non-small cell lung cancer: a multicentric analysis on behalf of AIRO lung cancer study group. La radiologia medica. 124(7). 662–670. 32 indexed citations

19.

Bonomo, Pierluigi, Daniela Greto, Isacco Desideri, et al.. (2019). Clinical outcome of stereotactic body radiotherapy for lung-only oligometastatic head and neck squamous cell carcinoma: Is the deferral of systemic therapy a potential goal?. Oral Oncology. 93. 1–7. 34 indexed citations

20.

Scoccianti, Silvia, Giulio Francolini, Giulio Alberto Carta, et al.. (2018). Re-irradiation as salvage treatment in recurrent glioblastoma: A comprehensive literature review to provide practical answers to frequently asked questions. Critical Reviews in Oncology/Hematology. 126. 80–91. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact